Stocks and Investing
Stocks and Investing
Fri, August 11, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Laura Chico Maintained (VERA) at Hold with Increased Target to $16 on, Aug 11th, 2023
Laura Chico of Wedbush, Maintained "Vera Therapeutics, Inc." (VERA) at Hold with Increased Target from $12 to $16 on, Aug 11th, 2023.
Laura has made no other calls on VERA in the last 4 months.
There are 2 other peers that have a rating on VERA. Out of the 2 peers that are also analyzing VERA, 0 agree with Laura's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Laura
- Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Thursday, June 8th, 2023
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $22 on, Wednesday, April 12th, 2023
Contributing Sources